Growth Metrics

Nexgel (NXGL) Non Operating Investment Income (2022 - 2024)

Nexgel posted quarterly Non Operating Investment Income of $5000.0 for Q3 2024, down 88.64% year-on-year from $44000.0 in Q4 2023, and down 78.26% on a QoQ basis from $23000.0 in Q2 2024.

Nexgel (NXGL) has 3 years of Non Operating Investment Income data on file, last reported at $5000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -1.09 Mn
10 Nexgel 31,199.58 -1.34 Mn 819,000.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 5,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 23,000.00
Jun 30, 2024 23,000.00
Sep 30, 2023 44,000.00
Sep 30, 2023 44,000.00
Jun 30, 2023 116,000.00
Jun 30, 2023 116,000.00
Sep 30, 2022 5,000.00
Sep 30, 2022 5,000.00